{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T20:15:58Z","timestamp":1649189758058},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,8,24]],"date-time":"2013-08-24T00:00:00Z","timestamp":1377302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s00063-013-0219-1","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T08:25:23Z","timestamp":1377159923000},"page":"484-490","source":"Crossref","is-referenced-by-count":4,"title":["Droge ist nicht gleich Droge"],"prefix":"10.1007","volume":"108","author":[{"given":"L.S.","family":"Weilemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,24]]},"reference":[{"key":"219_CR1","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1073\/pnas.1204376109","volume":"109","author":"Absalon","year":"2012","unstructured":"Absalon N, Eghorst LF, Villumsen IS (2012) GABA receptors are high-affinity targets for gamma hydroxybuturic acid. Proc Natl Acad Sci U S A 109(33):13404\u201313409","journal-title":"Proc Natl Acad Sci U S A"},{"key":"219_CR2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/jms.1558","volume":"44","author":"Auw\u00e4rter","year":"2009","unstructured":"Auw\u00e4rter V et al (2009) Spice and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44(5):832\u2013837","journal-title":"J Mass Spectrom"},{"key":"219_CR3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.pra.0000413274.09305.9c","volume":"18","author":"Castellanos","year":"2012","unstructured":"Castellanos D, Thornton G (2012) Synthetic cannabinoid use: recognition and management. J Psychiatr Pract 18:86\u201393","journal-title":"J Psychiatr Pract"},{"key":"219_CR4","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2009) Understanding spice phenomenon, thematic papers. http:\/\/www.emcdda.europa.eu (Zugegriffen: 23.07.2013)"},{"key":"219_CR5","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1016\/j.bmcl.2010.05.065","volume":"20","author":"Gibbons","year":"2010","unstructured":"Gibbons S, Zloh M (2010) An analysis of the \u201elegal high\u201c mephedrone\u2019. Bioorg Med Chem Lett 20(14):4135\u20134139","journal-title":"Bioorg Med Chem Lett"},{"key":"219_CR6","doi-asserted-by":"crossref","first-page":"S463","DOI":"10.1124\/pr.55.3.3","volume":"55","author":"Green","year":"2003","unstructured":"Green AR (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201eecstasy\u201c). Pharmacol Rev 55:S463\u2013S508","journal-title":"Pharmacol Rev"},{"key":"219_CR7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00115-001-1243-6","volume":"73","author":"Gouzulis-Mayfrank","year":"2002","unstructured":"Gouzulis-Mayfrank E et al (2002) Neurotoxische Langzeitsch\u00e4den bei Ecstasy (MDMA) Konsum. \u00dcberblick \u00fcber den derzeitigen Wissensstand. Nervenarzt 73:405\u2013472","journal-title":"Nervenarzt"},{"key":"219_CR8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1360-0443.2012.04078.x","volume":"108","author":"Hermanns-Clausen","year":"2013","unstructured":"Hermanns-Clausen M, Kneisel S, Szabo B, Auw\u00e4rter V (2013) Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction 108:534\u2013544","journal-title":"Addiction"},{"key":"219_CR9","unstructured":"http:\/\/bka.de. Dokument Rauschgiftkriminalit\u00e4t. Zugegriffen Mai 2013"},{"key":"219_CR10","unstructured":"http:\/\/www.emcdda.europa.eu\/edr. Zugegriffen Mai 2013"},{"key":"219_CR11","unstructured":"http:\/\/www.homeoffice.gov.uk\/publications\/drugs\/acmd1\/acmd-cathinodes-report-2010. Zugegriffen Mai 2013"},{"key":"219_CR12","doi-asserted-by":"crossref","unstructured":"Huffmann JW (2009) Cannabimimetic indoles, pyrroles and indenes. Structure activity relationships and receptor interactions. In: Reggio PH (Hrsg) The cannabinoid receptors. Humana Press, Totowa NJ","DOI":"10.1007\/978-1-59745-503-9_3"},{"key":"219_CR13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1024\/1661-8157\/a000923","volume":"101","author":"Kupferschmidt","year":"2012","unstructured":"Kupferschmidt H (2012) Neue Drogen. Praxis 101:565\u2013570","journal-title":"Praxis"},{"key":"219_CR14","unstructured":"Meyer MR, Peters FT, Maurer HH (2009) Metabolism of the new designer drug mephedrone and toxicological detection of the beta keto designer drugs mephedrone, butylone and methylone in urine. Annales de Toxicologie Analytique 21"},{"key":"219_CR15","unstructured":"Sauer O, Weilemann LS (2000) Drogen-Eigenschaften-Wirkungen-Intoxikationen. Schl\u00fctersche, Hannover"},{"key":"219_CR16","first-page":"345","volume":"42","author":"Sauer","year":"2002","unstructured":"Sauer O, Weilemann LS (2002) Biogene Drogen und Designerdrogen. Intern Prax 42:345\u2013382","journal-title":"Intern Prax"},{"key":"219_CR17","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1056\/NEJMra044047","volume":"352","author":"Snead","year":"2005","unstructured":"Snead OC, Gibson KM (2005) Gamma-Hydroxybuturic acid. N Engl J Med 352:2721\u20132732","journal-title":"N Engl J Med"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-013-0219-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-013-0219-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-013-0219-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T02:13:35Z","timestamp":1558577615000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-013-0219-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,24]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["219"],"URL":"https:\/\/doi.org\/10.1007\/s00063-013-0219-1","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,24]]}}}